INTERNATIONAL IMMUNOPHARMACOLOGY

International Immunopharmacology is the primary vehicle for the publication of original research papers pertinent to the overlapping areas of immunology| pharmacology| cytokine biology| immunotherapy| immunopathology and immunotoxicology. Review articles that encompass these subjects are also welcome. The subject material appropriate for submission includes: • Clinical studies employing immunotherapy of any type including the use of: bacterial and chemical agents; thymic hormones| interferon| lymphokines| etc.| in transplantation and diseases such as cancer| immunodeficiency| chronic infection and allergic| inflammatory or autoimmune disorders. • Studies on the mechanisms of action of these agents for specific parameters of immune competence as well as the overall clinical state. • Pre-clinical animal studies and in vitro studies on mechanisms of action with immunopotentiators| immunomodulators| immunoadjuvants and other pharmacological agents active on cells participating in immune or allergic responses. • Pharmacological compounds| microbial products and toxicological agents that affect the lymphoid system| and their mechanisms of action. • Agents that activate genes or modify transcription and translation within the immune response. • Substances activated| generated| or released through immunologic or related pathways that are pharmacologically active. • Production| function and regulation of cytokines and their receptors. • Classical pharmacological studies on the effects of chemokines and bioactive factors released during immunological reactions.

数据整理自公开网络的投稿反馈，仅供参考。